Loading...
NPI 1043256118 · New Hartford, NY · Interventional Pain Medicine Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Ivan Antonevich is a interventional pain medicine physician provider located in New Hartford, New York. This profile covers 22 Medicare and 4 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Ivan Antonevich |
| Address | 1729 Burrstone Rd |
| City | New Hartford |
| State | NY |
| ZIP | 13413 |
| Taxonomy | Interventional Pain Medicine Physician |
| NPI Enumerated | June 20, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $262.7K |
| Medicaid | $18.3K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
22 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 790 | $90 | $72.2K |
| 62323 | The provider injects a diagnostic or a therapeutic substance, such as pain medication or a steroid, into the space around the spinal nerves of the lumbar (lower back) or sacral (caudal, or tailbone)… | 150 | $180 | $26.9K |
| 77002 | The provider uses fluoroscopic guidance to place a needle for biopsy, aspiration, injection, or localization of a device to detect any lesions in any area of the body, except for the spine, or to… | 280 | $90 | $24.3K |
| 64640 | Neurolysis is the destruction of nerves responsible for carrying pain information. The destruction includes the use of chemical, heat, or radiofrequency techniques. | 180 | $120 | $20.5K |
| 27096 | The provider performs an injection in the joint between the sacrum and ilium on one side of the body, with the aid of imaging equipment to locate the injection site. He injects an anesthetic to… | 140 | $120 | $16.6K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 130 | $120 | $15.8K |
| 64635 | Under fluoroscopic or CT guidance, the provider applies an agent to a lower back joint to destroy nerve tissue. | 40 | $330 | $12.2K |
| J7322 | Hyaluronan or derivative, hymovis or hymovis one, for intra-articular injection, 1 mg | 700 | $10 | $9K |
| 64493 | The provider injects a diagnostic or therapeutic substance into a single lumbar or sacral paravertebral facet (zygapophyseal) joint, or into the nerves that supply that joint, using imaging guidance… | 50 | $190 | $8.6K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 130 | $60 | $8.5K |
Showing 1–10 of 22
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 22 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
22 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J7322 | 34 | 40 | 1,440 | $10 | $30.5K |
| 64635 | 94 | 240 | 30 | $430 | $19.9K |
| 99214 | 1,279 | 30,450 | 90 | $100 | $19K |
| 64483 | 254 | 410 | 50 | $220 | $17.9K |
| 62323 | 63 | 390 | 50 | $190 | $15.4K |
| 64493 | 175 | 370 | 40 | $200 | $13.2K |
| 64640 | 3 | 30 | 80 | $140 | $12.4K |
| 99213 | 11,009 | 31,440 | 80 | $70 | $12.1K |
| 77002 | 18 | 310 | 30 | $100 | $10.9K |
| 62321 | 65 | 180 | 30 | $210 | $8.3K |
Showing 1–10 of 22
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
4 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 600 | $30 | $16.2K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 380 | $1 | $1.1K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 400 | $1 | $800 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care… | 30 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other New York providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New York median
4 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 5,437 | 16,550 | 220 | $90 | $186.8K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 233 | 660 | 170 | $1 | $3.2K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 28 | 110 | 80 | $10 | $2.8K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care… | 1,113 | 1,600 | 50 | $10 | $1.2K |
Other providers in the same ZIP code as Ivan Antonevich, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Joseph Gale | NY | Ophthalmology Physician | $2.4M | $213.6K |
| Steven Williams | NY | Ophthalmology Physician | $1.9M | $161.1K |
| Aziz Basem Nicholas Qandah | NY | Neurological Surgery Physician | $859.6K | $132.5K |
| Daniel Welchons | NY | Urology Physician | $435.9K | $5.8K |
| Ronald Kaye | NY | Urology Physician | $322.3K | $3.5K |
| Felix Oduwa | NY | Family Medicine Physician | $197.1K | $44.3K |
| Jay Daly | NY | Diagnostic Radiology Physician | $217.3K | $3.6K |
| Nancy Shaheen | NY | Diagnostic Radiology Physician | $188.7K | $9.3K |
| Anthony Mangano | NY | Diagnostic Radiology Physician | $155.9K | $5K |
| Eckerd Corporation | NY | Community/Retail Pharmacy | $78.2K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.